Proposed Rules. DEPARTMENT OF HEALTH AND HUMAN SERVICES

277 words·~1 min read·/register/2002/08/27/02-21801

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDA. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute on Drug Abuse, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* Board of Scientific Counselors, NIDA. *Date:* September 12-13, 2002. *Time:* 9:30 a.m. to 2 p.m. *Agenda:* To review and evaluate personal qualifications and performance, and competence of individual investigators. *Place:* Intramural Research Program, National Institute on Drug Abuse, Johns Hopkins Bayview Campus, Bldg.

C, 2nd Floor Auditorium, 5500 Nathan Shock Drive, Baltimore, MD 21224. *Contact Person:* Stephen J. Heishman, PhD, Research Psychologist, Clinical Pharmacology Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, 5500 Nathan Shock Drive, Baltimore, MD 21224,

(410)550-1547. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS) Dated: August 21, 2002. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 02-21801 Filed 8-26-02; 8:45 am]